Jun 01, 2020
CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial
May 27, 2020
Viking Therapeutics to Participate in Upcoming Investor Conferences
May 18, 2020
Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company
Apr 28, 2020
Viking Therapeutics to Participate in Upcoming Investor Conferences
Mar 27, 2020
Lisinopril Market Study 2020: Global Trends & Developments, Major Players, Patents, and More
Feb 28, 2020
HUYA Bioscience International® Announces the Successful Completion of Phase 1 Trial of HBI-3000
Feb 28, 2020
HUYA Bioscience International® Announces the Successful Completion of Phase 1 Trial of HBI-3000
Feb 26, 2020
Viking Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
Feb 19, 2020
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2019 on February 26, 2020
Feb 03, 2020
CTI BioPharma Establishes Accelerated Approval Pathway for Pacritinib in Treating Myelofibrosis Patients With Severe Thrombocytopenia
Jan 27, 2020
Global Sialorrhea Market Report 2017-2028: Current Treatment Practices, Emerging Drugs, Market Share of Individual Therapies, Current & Forecasted Market Size
Jan 06, 2020
Viking Therapeutics to Present at Biotech Showcase 2020
Nov 05, 2019
Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Oct 01, 2019
CTI BioPharma Begins Patient Enrollment in PACIFICA Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis Patients With Severe Thrombocytopenia
Aug 28, 2019
Viking Therapeutics to Participate in Upcoming Investor Conferences
Aug 01, 2019
CTI BioPharma Reports Second Quarter 2019 Financial Results
Jul 25, 2019
Viking Therapeutics to Report Financial Results for Second Quarter 2019 on August 1, 2019
Jul 02, 2019
Viking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of Directors
May 29, 2019
CTI BioPharma to Present at the Jefferies Global Healthcare Conference on Wednesday, Jun. 5
May 28, 2019
Viking Therapeutics to Participate in Upcoming Investor Conferences